Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CANNON: Enarodustat Hb Targets in ND-CKD Anemia
NCT06725810Phase 4Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Mar 2025
- Primary completion
- Jan 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of enarodustat in anemia of chronic kidney disease (CKD-A), sponsored by Zhongshan Hospital, Fudan University. Started Mar 2025; status: recruiting.
02
Drugs
enarodustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT06725810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06725810.